Anton Lennikov, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, CXCR5 | 3 | 2020 | 88 | 2.050 |
Why?
|
I-kappa B Kinase | 3 | 2018 | 250 | 1.340 |
Why?
|
Corneal Neovascularization | 7 | 2019 | 185 | 1.300 |
Why?
|
Retina | 10 | 2023 | 2663 | 1.190 |
Why?
|
Blood-Retinal Barrier | 2 | 2020 | 63 | 1.180 |
Why?
|
Retinal Degeneration | 3 | 2020 | 415 | 1.130 |
Why?
|
Cornea | 6 | 2021 | 1332 | 1.020 |
Why?
|
NF-kappa B | 6 | 2021 | 2491 | 0.990 |
Why?
|
Keratitis | 4 | 2018 | 241 | 0.990 |
Why?
|
Benzamides | 3 | 2018 | 1381 | 0.980 |
Why?
|
Streptozocin | 1 | 2024 | 195 | 0.920 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2024 | 1121 | 0.900 |
Why?
|
Retinal Pigment Epithelium | 4 | 2021 | 309 | 0.880 |
Why?
|
Microglia | 5 | 2023 | 1376 | 0.840 |
Why?
|
Uveitis | 4 | 2014 | 398 | 0.830 |
Why?
|
Pericytes | 2 | 2022 | 299 | 0.820 |
Why?
|
Behcet Syndrome | 4 | 2020 | 86 | 0.780 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2022 | 3520 | 0.730 |
Why?
|
Endothelial Cells | 6 | 2022 | 3586 | 0.650 |
Why?
|
Macular Degeneration | 4 | 2021 | 1016 | 0.620 |
Why?
|
Aqueous Humor | 3 | 2014 | 153 | 0.610 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 380 | 0.570 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 22365 | 0.550 |
Why?
|
Antioxidants | 4 | 2020 | 1678 | 0.500 |
Why?
|
Eye Proteins | 2 | 2018 | 633 | 0.480 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18390 | 0.480 |
Why?
|
Sea Urchins | 1 | 2014 | 45 | 0.460 |
Why?
|
Retinal Vessels | 3 | 2020 | 864 | 0.450 |
Why?
|
Naphthoquinones | 1 | 2014 | 59 | 0.450 |
Why?
|
Diabetic Retinopathy | 3 | 2020 | 1299 | 0.410 |
Why?
|
Diterpenes | 1 | 2013 | 170 | 0.400 |
Why?
|
Ultraviolet Rays | 3 | 2017 | 1100 | 0.380 |
Why?
|
Autoimmunity | 1 | 2019 | 1361 | 0.380 |
Why?
|
Capillary Permeability | 1 | 2014 | 773 | 0.360 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1890 | 0.360 |
Why?
|
Epithelium, Corneal | 2 | 2020 | 254 | 0.360 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2013 | 395 | 0.360 |
Why?
|
Prodrugs | 1 | 2012 | 274 | 0.350 |
Why?
|
Stomatitis, Aphthous | 2 | 2020 | 51 | 0.340 |
Why?
|
Blood Glucose | 1 | 2024 | 6429 | 0.340 |
Why?
|
Glucosephosphate Dehydrogenase | 2 | 2020 | 209 | 0.310 |
Why?
|
Animals | 36 | 2024 | 169424 | 0.280 |
Why?
|
Nerve Regeneration | 2 | 2024 | 801 | 0.270 |
Why?
|
Angiogenesis Inhibitors | 4 | 2019 | 2062 | 0.270 |
Why?
|
Signal Transduction | 8 | 2024 | 23639 | 0.250 |
Why?
|
Neovascularization, Pathologic | 4 | 2020 | 2643 | 0.250 |
Why?
|
Mice | 17 | 2024 | 82051 | 0.230 |
Why?
|
Rats, Wistar | 5 | 2019 | 1891 | 0.230 |
Why?
|
Apoptosis | 3 | 2020 | 9526 | 0.220 |
Why?
|
Capillaries | 2 | 2018 | 756 | 0.220 |
Why?
|
Rats, Inbred Lew | 3 | 2014 | 1165 | 0.210 |
Why?
|
Rats | 11 | 2019 | 23839 | 0.210 |
Why?
|
Angiopoietins | 1 | 2022 | 86 | 0.200 |
Why?
|
Dexamethasone | 3 | 2019 | 1965 | 0.190 |
Why?
|
Lacrimal Apparatus | 1 | 2023 | 223 | 0.190 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 452 | 0.190 |
Why?
|
Epithelial Cells | 2 | 2020 | 3697 | 0.190 |
Why?
|
Corneal Edema | 1 | 2021 | 47 | 0.190 |
Why?
|
Zebrafish | 4 | 2021 | 3038 | 0.190 |
Why?
|
Endotoxins | 2 | 2014 | 520 | 0.180 |
Why?
|
Periodic Acid-Schiff Reaction | 1 | 2020 | 16 | 0.180 |
Why?
|
Keratoconus | 1 | 2022 | 113 | 0.180 |
Why?
|
Inflammation | 7 | 2023 | 10863 | 0.180 |
Why?
|
Mice, Knockout | 3 | 2020 | 14483 | 0.180 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2020 | 27 | 0.170 |
Why?
|
Chemokine CXCL13 | 1 | 2020 | 62 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 808 | 0.170 |
Why?
|
alpha-Crystallin B Chain | 1 | 2019 | 24 | 0.170 |
Why?
|
Anti-Inflammatory Agents | 3 | 2020 | 1816 | 0.170 |
Why?
|
Goblet Cells | 1 | 2022 | 300 | 0.170 |
Why?
|
Tauopathies | 1 | 2023 | 328 | 0.160 |
Why?
|
Corneal Stroma | 1 | 2020 | 170 | 0.160 |
Why?
|
Glutamic Acid | 1 | 2024 | 1192 | 0.160 |
Why?
|
Coculture Techniques | 1 | 2022 | 1343 | 0.160 |
Why?
|
Calcium Channels, L-Type | 1 | 2020 | 242 | 0.150 |
Why?
|
Retinal Ganglion Cells | 1 | 2024 | 811 | 0.150 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2020 | 203 | 0.150 |
Why?
|
Retinoid X Receptor alpha | 1 | 2018 | 22 | 0.150 |
Why?
|
Phospholipases A2 | 2 | 2019 | 197 | 0.150 |
Why?
|
Electroretinography | 1 | 2020 | 524 | 0.150 |
Why?
|
Uveal Neoplasms | 1 | 2021 | 344 | 0.150 |
Why?
|
Dry Eye Syndromes | 1 | 2022 | 388 | 0.150 |
Why?
|
Caspase 3 | 1 | 2020 | 732 | 0.150 |
Why?
|
Tissue Scaffolds | 1 | 2024 | 948 | 0.150 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 699 | 0.140 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 599 | 0.140 |
Why?
|
Calcium Channel Blockers | 1 | 2020 | 692 | 0.140 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 969 | 0.140 |
Why?
|
Xanthophylls | 2 | 2017 | 95 | 0.140 |
Why?
|
Cells, Cultured | 5 | 2020 | 19035 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5709 | 0.130 |
Why?
|
Receptors, Chemokine | 1 | 2019 | 655 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2024 | 1389 | 0.130 |
Why?
|
Cadherins | 1 | 2020 | 906 | 0.120 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2150 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1104 | 0.120 |
Why?
|
Drug Discovery | 2 | 2020 | 1062 | 0.120 |
Why?
|
Gene Regulatory Networks | 3 | 2020 | 1760 | 0.120 |
Why?
|
Pyridoxamine | 1 | 2014 | 10 | 0.120 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 757 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2477 | 0.120 |
Why?
|
Hydrogels | 1 | 2020 | 745 | 0.120 |
Why?
|
Retinitis | 1 | 2014 | 36 | 0.120 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1085 | 0.120 |
Why?
|
Choroidal Neovascularization | 2 | 2021 | 364 | 0.120 |
Why?
|
Male | 21 | 2024 | 364761 | 0.120 |
Why?
|
Moscow | 1 | 2013 | 6 | 0.120 |
Why?
|
Gene Expression | 3 | 2019 | 7605 | 0.110 |
Why?
|
Microfilament Proteins | 1 | 2019 | 1136 | 0.110 |
Why?
|
Isomerism | 1 | 2014 | 198 | 0.110 |
Why?
|
Body Weight | 1 | 2024 | 4630 | 0.110 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1020 | 0.110 |
Why?
|
HLA-A Antigens | 1 | 2013 | 223 | 0.110 |
Why?
|
Chemokine CCL2 | 2 | 2013 | 607 | 0.110 |
Why?
|
Tissue Kallikreins | 1 | 2013 | 14 | 0.110 |
Why?
|
Russia | 1 | 2013 | 386 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2020 | 2640 | 0.100 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1563 | 0.100 |
Why?
|
Blotting, Western | 1 | 2020 | 5042 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 2003 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1349 | 0.100 |
Why?
|
Collagen | 1 | 2020 | 2646 | 0.100 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 413 | 0.100 |
Why?
|
Biocompatible Materials | 1 | 2020 | 1703 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4362 | 0.100 |
Why?
|
Administration, Oral | 3 | 2017 | 4040 | 0.100 |
Why?
|
Lung Diseases | 1 | 2021 | 1926 | 0.090 |
Why?
|
Cytoprotection | 1 | 2012 | 201 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 1 | 2012 | 616 | 0.090 |
Why?
|
Injections | 1 | 2014 | 840 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4355 | 0.090 |
Why?
|
Ophthalmic Solutions | 1 | 2012 | 315 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10784 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 396 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13709 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3439 | 0.080 |
Why?
|
Pentose Phosphate Pathway | 2 | 2020 | 126 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2819 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3549 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11928 | 0.080 |
Why?
|
Lysosomes | 1 | 2013 | 934 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4613 | 0.070 |
Why?
|
Cell Movement | 1 | 2019 | 5223 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 2958 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2019 | 548 | 0.070 |
Why?
|
Age of Onset | 1 | 2013 | 3342 | 0.070 |
Why?
|
Data Mining | 2 | 2021 | 561 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2216 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2019 | 3892 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2020 | 3145 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15610 | 0.060 |
Why?
|
Polyglutamic Acid | 1 | 2024 | 47 | 0.060 |
Why?
|
Proteomics | 1 | 2018 | 3901 | 0.060 |
Why?
|
Rabbits | 2 | 2021 | 4786 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2465 | 0.060 |
Why?
|
Humans | 18 | 2023 | 768369 | 0.060 |
Why?
|
Bioengineering | 1 | 2024 | 100 | 0.060 |
Why?
|
Optic Nerve Injuries | 1 | 2024 | 150 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11139 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5740 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2023 | 208 | 0.050 |
Why?
|
Corneal Topography | 1 | 2022 | 69 | 0.050 |
Why?
|
Fluorescein | 1 | 2022 | 175 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2020 | 1339 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2260 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13643 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16712 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 251 | 0.050 |
Why?
|
Homeostasis | 2 | 2023 | 3351 | 0.050 |
Why?
|
Phosphorylation | 1 | 2012 | 8331 | 0.050 |
Why?
|
Refraction, Ocular | 1 | 2022 | 186 | 0.050 |
Why?
|
Tears | 1 | 2022 | 252 | 0.050 |
Why?
|
Optic Nerve | 1 | 2024 | 572 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2021 | 210 | 0.040 |
Why?
|
Mongolia | 1 | 2020 | 93 | 0.040 |
Why?
|
Light Signal Transduction | 1 | 2020 | 31 | 0.040 |
Why?
|
Porosity | 1 | 2020 | 352 | 0.040 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2020 | 95 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16023 | 0.040 |
Why?
|
X-Ray Diffraction | 1 | 2020 | 418 | 0.040 |
Why?
|
Conjunctiva | 1 | 2022 | 478 | 0.040 |
Why?
|
Tryptophan | 1 | 2021 | 483 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1840 | 0.040 |
Why?
|
Female | 9 | 2023 | 396926 | 0.040 |
Why?
|
NADP | 1 | 2020 | 230 | 0.040 |
Why?
|
Genome | 2 | 2017 | 1750 | 0.040 |
Why?
|
Basement Membrane | 1 | 2019 | 349 | 0.040 |
Why?
|
Glutathione Peroxidase | 1 | 2019 | 259 | 0.040 |
Why?
|
Inflammasomes | 1 | 2023 | 541 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2022 | 1743 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2020 | 709 | 0.040 |
Why?
|
Glutathione | 1 | 2020 | 587 | 0.040 |
Why?
|
Lasers | 1 | 2021 | 952 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 784 | 0.030 |
Why?
|
PPAR alpha | 1 | 2018 | 177 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15879 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1051 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 560 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 854 | 0.030 |
Why?
|
Eye | 1 | 2020 | 715 | 0.030 |
Why?
|
Young Adult | 3 | 2021 | 60038 | 0.030 |
Why?
|
Administration, Topical | 1 | 2017 | 707 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 621 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2126 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 617 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1335 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 64 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 963 | 0.030 |
Why?
|
Retinol-Binding Proteins | 1 | 2014 | 67 | 0.030 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2014 | 22 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 752 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2232 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 873 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2841 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1977 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2819 | 0.030 |
Why?
|
Bradykinin | 1 | 2013 | 205 | 0.030 |
Why?
|
Swine | 1 | 2022 | 5996 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2022 | 1890 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9508 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2019 | 1754 | 0.020 |
Why?
|
Headache | 1 | 2020 | 1260 | 0.020 |
Why?
|
Adult | 5 | 2021 | 223528 | 0.020 |
Why?
|
Middle Aged | 5 | 2021 | 223406 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2030 | 0.020 |
Why?
|
Laser Coagulation | 1 | 2013 | 333 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4931 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4132 | 0.020 |
Why?
|
Choroid | 1 | 2013 | 363 | 0.020 |
Why?
|
Adolescent | 2 | 2020 | 89163 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2170 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2226 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2728 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2013 | 1133 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3793 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2014 | 539 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59679 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1964 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5912 | 0.020 |
Why?
|
Aged | 4 | 2021 | 171514 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3813 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7440 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13447 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3234 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2014 | 5151 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17637 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22286 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39429 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4789 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54913 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27439 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30235 | 0.010 |
Why?
|
Child | 1 | 2020 | 80856 | 0.010 |
Why?
|